---
figid: PMC4748715__nihms-751692-f0008
figtitle: Model summarizing the epigenetically regulated MLL2/FOXO/BRD4/c-Myc- axis
  in reducing the sensitivity of the HER2+ breast cancer cells to Lapatinib, and the
  synergy of Lapatinib and IBET in suppressing HER2+ breast cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4748715
filename: nihms-751692-f0008.jpg
figlink: /pmc/articles/PMC4748715/figure/F8/
number: F8
caption: A model summarizing the epigenetically regulated MLL2/FOXO/BRD4/c-Myc- axis
  in reducing the sensitivity of the HER2+ breast cancer cells to Lapatinib, and the
  synergy of Lapatinib and IBET in suppressing HER2+ breast cancer.
papertitle: An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to
  HER2 Inhibition via FOXO/c-Myc Axis.
reftext: Smita Matkar, et al. Cancer Cell. ;28(4):472-485.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9527886
figid_alias: PMC4748715__F8
figtype: Figure
redirect_from: /figures/PMC4748715__F8
ndex: c740482b-deef-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4748715__nihms-751692-f0008.html
  '@type': Dataset
  description: A model summarizing the epigenetically regulated MLL2/FOXO/BRD4/c-Myc-
    axis in reducing the sensitivity of the HER2+ breast cancer cells to Lapatinib,
    and the synergy of Lapatinib and IBET in suppressing HER2+ breast cancer.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - foxo
  - Myc
  - DCTN6-p27
  - dap
  - CG9588
  - Gcn5
  - ERBB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - KMT2D
  - KMT2B
  - CXCR1
  - MYC
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - BCL2L11
  - KAT2A
  - Cancer
---
